Bio Decontamination Market

The global bio decontamination market in terms of revenue was estimated to be worth $238 million in 2023 and is poised to reach $339 million by 2028, growing at a CAGR of 7.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven by the increased outsourcing of bio decontamination services and Growing healthcare sector and increasing outsourcing in emerging economies. However, Challenges associated with Variability of pathogen resistance may threat the growth of this market.

Attractive Opportunities in the Bio Decontamination Market

To know about the assumptions considered for the study, Request for Free Sample Report

Recession Impact on the Bio Decontamination Market

The impact of a recession on the market is increased competition. As organizations become more price-sensitive, they may seek bio decontamination providers or technologies at a lower cost, potentially leading to price pressure and decreased profit margins for existing providers.

However, the market may also be somewhat recession-resistant, as certain industries, such as healthcare and pharmaceuticals, may continue to require bio decontamination services regardless of economic conditions. Additionally, as the importance of public health and safety is emphasized during times of crisis, such as a pandemic, there may be increased awareness and demand for bio decontamination services and technologies.

Bio Decontamination Dynamics

DRIVER: Rising growth in pharmaceutical & biotechnology industries

Bio decontamination equipment, services, consumables, and accessories are widely used in pharmaceutical companies, especially in parenteral (injectable) manufacturing. According to the European Federation of Pharmaceutical Industries & Associations (EFPIA), the global pharmaceuticals were USD 1,077,856 in 2020. Furthermore, according to the Pharmaceutical Executive, the top 15 pharmaceutical companies invested USD 133 billion in 2021 in R&D expenditure. With the rising R&D expenditure and the increasing focus on the development of new therapeutic and diagnostic products, the demand for state-of-the-art facilities equipped with modern machines & instruments and a properly decontaminated environment (for efficient & effective research and manufacturing) is expected to increase in the coming years. This is considered a positive indicator for the growth of the market during the forecast period.

OPPORTUNITY: Growing healthcare sector and increasing outsourcing in emerging economies

Emerging markets, such as India and China, are considered cost-saving hubs by developed countries. During the last decade, businesses in developed markets, such as the US and Europe, have outsourced their manufacturing and packaging operations to China, South Korea, Taiwan, and India to leverage the lower labor costs and less-stringent government regulations in these countries. As these countries are becoming major manufacturing hubs, there is a greater focus on quality parameters and the adoption of technologically advanced products to cater to customer requirements. Consequently, the adoption of bio decontamination products & services is growing across many industries in these countries. According to Dezan Shira & Associates (2020), by 2030, China is expected to account for more than 25% of the global medical device industry (at over USD 200 billion) as decontamination is an essential service in medical devices hence the market is anticipated grow. Moreover, setting up and maintaining in-house bio decontamination capabilities may be expensive. Outsourcing allows them to benefit from economies of scale, as service providers can leverage their resources across multiple clients, resulting in potential cost savings for the healthcare facility this will support to thrive the market in emerging economies during the forecast period.

CHALLENGE: Variability of pathogen-resistance

The variability of pathogen challenge is an important consideration in the market. Different pathogens have varying levels of resistance, persistence, and susceptibility to decontamination methods. Here are some key factors that contribute to the variability of pathogen challenge in bio decontamination:

Pathogen Types: Different types of pathogens pose varying challenges in terms of their resistance and susceptibility to decontamination. Bacteria, viruses, fungi, and spores all have different characteristics and responses to disinfectants and decontamination methods. For example, spores such as those produced by Clostridium difficile, or Bacillus anthracis can be particularly resistant and challenging to eliminate.

Pathogen Resistance: Pathogens can develop resistance to disinfectants and antimicrobial agents over time. Factors such as genetic mutations, adaptation, or exposure to sublethal doses of disinfectants can contribute to the development of resistance. Some pathogens may have inherent resistance mechanisms that make them more difficult to eradicate.

Environmental Conditions: Pathogens can exhibit different levels of survival and persistence under varying environmental conditions. Factors such as temperature, humidity, pH, and the presence of organic matter can influence the viability and susceptibility of pathogens to decontamination methods. Some pathogens may survive longer in certain environments, making them more challenging to eliminate.

Surface Contamination: Pathogens can adhere to surfaces and form biofilms, which provide protective barriers and increase their resistance to disinfection. The type of surface, its texture, porosity, and the presence of organic or inorganic matter can affect the ability of disinfectants to reach and eliminate pathogens effectively.

US accounted for the largest share of the North American bio decontamination market in 2022.

Based on the region, the North American market is segmented into US and Canada. In 2022, the US accounted for the largest share of the North American market. Growth in this market can be attributed to presence of stringent regulatory standard, rising healthcare expenditure, rising focus on infection control, the increasing number of surgical procedures performed in the US as Hospitals & healthcare facilities need to be decontaminated, especially in critical areas such as ICUs and operation theatres, the rising geriatric population, presence of majority of key players, and chronic diseases.

China registered the highest growth rate in Asia Pacific bio decontamination market

The APAC market is segmented into Japan, China, India, and Rest of Apac. In 2022, China accounted for the highest growth rate of the Asian market. The high growth rate of China can be attributed to expanding occurrences of HAIs, expansion of pharma, biotech and med tech companies, and alteration of healthcare infrastructure.

Germany in European bio decontamination market to witness the growth rate during the forecast period.

The Europe Market is segmented into Germany, Italy, France, Spain, the UK, and the Rest of Europe. Germany is registered the highest growth rate during the forecast period. The major factors contributing to the growth of this market are the climbing old age population, upsurging incidence infectious diseases, moreover Germany is leading manufacturers of high-quality medical equipment which results high requirement for bio decontamination products and services used by medical device manufacturers.

To know about the assumptions considered for the study, download the pdf brochure

Some of the major players operating in this market are Steris (US), Ecolab (US), TOMI Environmental Solutions, Inc (US). In 2022, Ecolab (US), held the leading position in the market. The company has a strong geographic presence across North America, Europe, and Asia Pacific. Steris PLC (US), held the second position in the bio decontamination market in 2022.  

Bio Decontamination Market Report Scope

This research report categorizes the bio decontamination market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Service

• Equipment
• Services
• Consumables

By Agent Type

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

By Type

• Chamber Decontamination
• Room Decontamination

By End User

• Pharmaceutical & Medical Device Manufacturing Companies
• Life Sciences & Biotechnology Research Organizations
• Hospitals & Healthcare Facilities

By Region

• North America
• Europe
• Apac
• RoW

Recent Developments

• In July 22, Ecolab’s (US) Bioquell HPV-AQ received an authorized approval for use in all territories of the European Union and the European Economic Area.
• In Dec 2022, the TOMI Environmental Solutions, Inc (US) launched new SteraMist products, which include the Select Plus-a hybrid product consisting of the Company’s current Surface Select and Environment systems. (The system is 24 volts, allowing for universal outlet usage and convert more of the hydrogen peroxide BIT Solution to hydroxyl radicals thus lowering H2O2 PPM levels allowing for faster turnaround time).

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst